L. Vo

发表

Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis

K. Fahrbach, J. Mardekian, S. Deitelzweig, 2018, Current medical research and opinion.

Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost

Y. Tabak, Benjamin A Lipsky, J. Weigelt, 2010, Diabetologia.

Real-world comparison of all-cause hospitalizations, hospitalizations due to stroke and major bleeding, and costs for non-valvular atrial fibrillation patients prescribed oral anticoagulants in a US health plan

A. Amin, J. Trocio, O. Dina, 2018, Journal of medical economics.

Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study.

M. Kollef, J. Schein, A. Shorr, 2011, The Journal of infection.

Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.

Robert A. Mendes, D. Dills, C. Zheng, 2015, Journal of managed care & specialty pharmacy.

Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies

S. Deitelzweig, C. Farmer, X. Luo, 2017, Current medical research and opinion.

PDB8 PREVALENCE OF DIABETES MELLITUS AND TREATMENT PATTERNS BASED ON CLASSIFICATION OF BODY MASS INDEX AMONG ADULTS

D. Suh, L. Vo, Hyunchul Shin, 2005 .

Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings

J. Trocio, O. Dina, P. Hlavacek, 2018, ClinicoEconomics and outcomes research : CEOR.

Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis

A. Amin, O. Dina, L. Vo, 2022, Current medical research and opinion.

PNL5 DRUG PERSISTENCY OF TWO CHOLINESTERASE INHIBITORS—RIVASTIGMINE VERSUS DONEPEZIL AMONG ELDERLY PATIENTS WITH ALZHEIMER'S DISEASE

D. Suh, S. Arcona, L. Vo, 2005 .

Abstract 19672: Comparison of Major-bleeding Risk and Health Care Costs Among Treatment-naïve Non-valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin

A. Amin, O. Baser, J. Trocio, 2015 .

Tinea capitis in the United States: Diagnosis, treatment, and costs.

D. Suh, S. Friedlander, L. Vo, 2006, Journal of the American Academy of Dermatology.

Imipenem Resistance in Pseudomonas aeruginosa Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes

M. Synnestvedt, W. Bilker, J. Schein, 2010, Infection Control & Hospital Epidemiology.

Real-world treatment patterns in resectable (stages I-III) non-small-cell lung cancer: a systematic literature review.

L. Vo, S. Goring, N. Waser, 2022, Future oncology.

Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii

M. Synnestvedt, W. Bilker, J. Schein, 2009, Infection Control & Hospital Epidemiology.

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population

A. Amin, O. Baser, J. Trocio, 2018, Journal of managed care & specialty pharmacy.

Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early view

O. Baser, J. Trocio, J. Mardekian, 2016, Journal of medical economics.

Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice

A. Cohen, J. Mardekian, L. Vo, 2018, Thrombosis and Haemostasis.

Comparison of opioid doctor shopping for tapentadol and oxycodone: a cohort study.

M Soledad Cepeda, D. Fife, L. Vo, 2013, The journal of pain : official journal of the American Pain Society.

The Health Care and Productivity Costs of Back and Neck Pain in A Multi-Employer Sample of Utility Industry Employees

A. Rodday, W. Rogers, D. Lerner, 2015, Journal of occupational and environmental medicine.

A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes

Benjamin A Lipsky, L. Napolitano, G. Moran, 2012, BMC Infectious Diseases.

Treatment and discharge patterns among patients hospitalized with non-valvular atrial fibrillation transitioning from the inpatient to outpatient setting

J. Trocio, H. Henk, J. Mardekian, 2018, Current medical research and opinion.

Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization

L. Vo, L. Montejano, D. Mcmorrow, 2015, Diabetes Therapy.

Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections in Hospitalized Patients

M. Zervos, L. Vo, K. Freeman, 2011, Journal of Clinical Microbiology.

Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study.

Benjamin A Lipsky, L. Boulanger, L. Napolitano, 2014, Diagnostic microbiology and infectious disease.

Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors.

Benjamin A Lipsky, L. Napolitano, G. Moran, 2014, Diagnostic microbiology and infectious disease.

Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012)

L. Vo, A. Ward, P. Alvarez, 2014, Journal of medical economics.

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population

A. Amin, O. Baser, J. Trocio, 2018, Journal of managed care & specialty pharmacy.

SAFETY AND EFFECTIVENESS OF APIXABAN VERSUS WARFARIN IN THE TREATMENT AND PREVENTION OF VENOUS THROMBOEMBOLISM

J. Mardekian, L. Vo, Xuemei Luo, 2018 .

Drug Persistency of Two Cholinesterase Inhibitors

D. Suh, S. Arcona, L. Vo, 2005, Drugs & aging.

Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population

A. Amin, O. Baser, J. Trocio, 2017, Current medical research and opinion.

Opioid analgesic-treated chronic pain patients at risk for problematic use.

J. Volpicelli, C. Ruetsch, L. Vo, 2013, The American journal of managed care.

Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States

M. Willis, C. Neslusan, L. Vo, 2018, Diabetes Therapy.

Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors.

Benjamin A Lipsky, L. Napolitano, G. Moran, 2014, Diagnostic microbiology and infectious disease.

The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients

J. Meigs, R. Grant, E. Huang, 2006, Current medical research and opinion.